Evidence map›Paper›PMID 31754399›Full record

ArticleTheranostics2019

Haiyan Chen, Xusheng Wang, Yu Chen, Jimin Han, Deqiang Kong, Meizhong Zhu, Xiaobing Fu, Yaojiong Wu

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Haiyan ChenTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Xusheng WangTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Yu ChenTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Jimin HanTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Deqiang KongTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Meizhong ZhuShenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University), Guangdong China.
Xiaobing FuWound Healing and Cell Biology Laboratory, Institute of Basic Medical Science, Chinese PLA General Hospital, Beijing, China; Stem Cell and Tissue Regeneration Laboratory, The First Affiliated Hospital, General Hospital of PLA, Beijing, China.
Yaojiong WuTsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua University, Guangdong, China.
Tsinghua–Berkeley Shenzhen Institute · CNChinese PLA General Hospital · CNSun Yat-sen University · CNUniversity Town of Shenzhen · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating data support that tissue stem cells give rise to cancer cells. Hair follicle stem cells (HFSCs) undergo cyclic quiescence and activation and may sever as the origin of cutaneous squamous cell carcinoma (SCC).

Indexed as

AnimalsBlotting, WesternCarcinoma, Squamous CellFemaleFluorescent Antibody TechniqueHair FollicleMiceMice, Inbred C57BLPTEN PhosphohydrolaseReceptors, G-Protein-CoupledSignal TransductionSkin NeoplasmsStem CellsLgr5 protein, mousePTEN PhosphohydrolasePten protein, mouseReceptors, G-Protein-Coupledhair folliclesPtenSCCTNFβ-catenin

Identifiers

PMID31754399
PMCPMC6857063
OpenAlexW2982419308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.